Drawing for BIONIC-I

USPTO serial 88985470

BIONIC-I

Reviewed by CopyMark Law Group

Reg. 7854397Status 700Registered
Filing date
Status date
Registration date
Jul 8, 2025
Examiner
GAGLIARDI, JEANINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIONIC-I?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R Menker

James R Menker HOLLEY & MENKER, PAPO BOX 331937ATLANTIC BEACH, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
005Capsules sold empty for pharmaceuticals; diagnostic reagents for medical diagnostic use; neurologic medications for treating brain injury, spinal cord injury, and seizure disorders, metabolic medications for treating diabetes, gout, arthritis, and anemia, psychoactive medications; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, brain, movement, and spinal cord diseases; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia; anti-inflammatory and antipyretic preparations; antibiotics; anticonvulsants; antidepressants; antidiabetic pharmaceuticals; antidiabetic preparations; antifungal medications; antihistamines; antiparasitics; antipyretics in the nature of antipyretic analgesics; antitumor drugs, namely, pharmaceutical preparations for treating tumors; antivirals; bactericides; beta blockers; biocides; chemotherapeutics; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; dietetic substances consisting of vitamins, minerals, amino acids and trace elements, namely, dietetic infusions for medical use being intravenous fluids used for nutrition; diuretics; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; electrolytes for medical use; empty capsules for pharmaceutical purposes; fungal medications; hydrocortisone; analgesics; insulin; insulin injectors sold filled with insulin; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; medical diagnostic reagents and assays for testing of body fluids; mixed antibiotic preparations; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations and agents for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; steroids; surgical anesthetics; medical adhesives for binding wounds, namely, surgical adhesives; tumor suppressing agentsACTIVE—
009Acceleration sensors; analogue to digital converters; downloadable facial recognition software; downloadable facial analysis software; protective face shields for protective helmets; fashion eyeglasses; fashion spectacles; flight simulators; protective helmets for boxing; protective helmets for sports; safety helmets; sandglasses; ski goggles; ski helmets; smart watches; spectacle frames; spectacle holders; sports helmets; touch screens; vehicle drive training simulators; workmen's protective face-shields; smartwatches in the nature of wristwatches featuring a cellphone and display screen for viewing, sending and recording text messages and emails; Dosage dispensers in the nature of machines for dispensing pre-determined dosages of medicationACTIVE—
010Apparatus used in implementing diagnosis tests designed to detect neurologic disease, metabolic disease, cardiovascular disease, inflammatory disease; medical apparatus for facilitating the administration of pharmaceutical preparations; blood glucose meters; blood glucose monitors for medical purposes; diabetes monitoring equipment for sampling and analyzing blood and body tissue in the nature of medical test kits for diabetes monitoring for home use; devices for measuring blood sugar; devices for measuring intracranial pressure; electrodes for medical purposes; electronic muscle stimulators for medical purposes; electronic nerve stimulators for medical purposes; forceps for medical use; heart rate monitors; heartbeat measuring apparatus; high frequency electromagnetic therapy apparatus; injection instruments without needles; lasers for surgical and medical use; magnetic resonance imaging apparatus for medical purposes; medical electrode; medical guidewires and parts and fittings therefor; medical image processors; medical ultrasound apparatus; ophthalmometers; ophthalmoscopes; optometric instruments, namely, instruments for measuring the diameter of ophthalmic lenses; surgical forceps; surgical mesh comprised primarily of artificial materials; syringes for medical purposes; thermometers for medical purposesACTIVE—
035Advertising and business management consultancy; advertising by transmission of on-line publicity for third parties through electronic communications networks; advertising relating to pharmaceutical products and in-vivo imaging products of others; advertising the goods and services of others; advertising the goods and services of others via electronic media and specifically the internet; business management advice; compilation of statistics; computerized market research services; cost analysis; management and compilation of computerized databases; market research services; providing business marketing information for others; advertising on the Internet for others; business management; business management consultancy; business strategy planning; database management; promoting the goods and services of others through advertisements on Internet websites; advertising services in the nature of providing marketing strategies for others; retail pharmacy servicesACTIVE—
038Telecommunication services, namely, personal communication services (PCS); telecommunications services, namely, electronic exchange of data in the nature of voice, audio, video, text and graphics stored in databases accessible via the Internet, computer networks and wireless communications networks; instant messaging services; mobile phone communication services; voice over internet protocol (VOIP) services; web messaging services; audio teleconferencing; video teleconferencing; video broadcasting services over the internet or other communication networks, namely, electronically transmitted video, audio, and audio visual content in the nature of television programs, movies, music video and user uploaded video clips; providing access to computer databases in the fields of social networking; telephone voice and text messaging services over computer and global communication networks; call diversion services in the nature of call forwarding services; telephone services, namely, cell phone services; cellular telephone communication; cellular text messaging services; communication by means of mobile phones; e-mail services in the nature of electronic transmission of e-mail; e-mail transmission services, namely, electronic transmission of e-mail; electronic mail services in the nature of electronic transmission of electronic mail; email services in the nature of electronic transmission of email; telephone services, namely, mobile phone services; paging by radio; providing access to the Internet; providing electronic mail services, namely, electronic transmission of electronic mail; providing voice chat services; secure electronic mail services in the nature of secure electronic transmission of electronic mail; video conferencing services; teleconferencing and video conferencing services; voice mail services; wireless digital messaging servicesACTIVE—
041Augmented reality video production; entertainment services in the nature of non-downloadable continuing television shows and movies in the fields of variety, news, and comedy transmitted via the internet; entertainment services in the nature of providing non-downloadable videos and images featuring television shows and movies transmitted via wireless computer networks; health clubs for physical exercise; instruction in martial arts; language instruction; language interpretation; language interpreter services; language training services; law enforcement training services; meditation training; motion picture and video rental services; museum services; music composition; music composition services; music transcription; night club services; nursery school services; officiating at sports competition; online casino gaming services, namely, providing on-line casino games; online gambling services; photographic computer imaging; physical education; physical education services; physical fitness instruction; piano instruction; planetarium services; practical training in the field of welding; providing entertainment information in the field of television programming; providing information in the field of exercise via an interactive website; providing news, editorials, and opinions concerning current events via a website; sign language interpretation; translation; tutoring in the fields of science and medicine; wagering servicesACTIVE—
042Providing temporary use of non-downloadable facial recognition software; providing temporary use of non-downloadable facial analysis software; colour analysis in the nature of laboratory services; medical laboratory services in the nature of analysis services for diagnostic and treatment purposesACTIVE—
044Preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications; providing information to patients in the field of administering medications; medical services in the nature of medical and surgical diagnostic services; medical imaging; medical screening; pharmacy dispensary services, namely, preparation of prescriptions in pharmacies; pharmaceutical advice; pharmaceutical consultancy services; medical services in the nature of conducting of medical examinations; addiction treatment services; cosmetic and colour analysis for cosmetic purposes; healthcare in the nature of eyecare services; health and beauty care services provided by saunas, beauty salons, sanatoriums, hairdressing salons and massage parlors; health care services provided by a health spa; medical services in the nature of light therapy services; medical house call services; medical testing services; mental health screening services; psychological diagnosis services; health counselling, namely, meditation counsellingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 8, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 20, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 22, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 12, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 12, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 12, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 12, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 12, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 12, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 10, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 27, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 9, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 9, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 21, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Aug 21, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 17, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 17, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 17, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 5, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 5, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 5, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 5, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Dec 5, 2023CNSLSUSPENSION LETTER WRITTEN—
Nov 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 23, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 23, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 23, 2023CNSISUSPENSION INQUIRY WRITTEN—
Aug 5, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 23, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 23, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jan 23, 2023CNSLSUSPENSION LETTER WRITTEN—
Jan 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 15, 2022GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 15, 2022GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 15, 2022CNSISUSPENSION INQUIRY WRITTEN—
Jun 22, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 1, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 1, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Dec 1, 2021CNSLSUSPENSION LETTER WRITTEN—
Nov 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2021ALIEASSIGNED TO LIE—
Nov 4, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 4, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 27, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 27, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Oct 27, 2020CNSLSUSPENSION LETTER WRITTEN—
Oct 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2020DOCKASSIGNED TO EXAMINER—
Apr 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance